Early serum TIMP-2 as a biomarker for 90-day chronic kidney disease after percutaneous coronary intervention in ST-elevation myocardial infarction: a prospective cohort study
BMC Cardiovascular Disorders · 06.05.2026 · 26 (1)
DOI: 10.1186/s12872-026-05904-8 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift BMC Cardiovascular Disorders, online erschienen am 06.05.2026. Verfasst von Miras Mugazov und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medical Care, Anesthesiology and Resuscitation, NJSC Karaganda Medical University, Karaganda, Kazakhstan. Hauptthemen laut MEDLINE: Tissue Inhibitor of Metalloproteinase-2, Percutaneous Coronary Intervention, ST Elevation Myocardial Infarction, Renal Insufficiency, Chronic. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Contrast-induced acute kidney injury (CI-AKI) remains a concern in patients with ST-elevation myocardial infarction (STEMI) undergoing emergent percutaneous coronary intervention (PCI), but creatinine-based CI-AKI definitions incompletely capture longer-term renal trajectories. Early tubular stress biomarkers such as tissue inhibitor of metalloproteinases-2 (TIMP-2) may provide incremental risk information beyond conventional functional markers.
Methods
In this prospective single-centre cohort, we enrolled 88 consecutive STEMI patients undergoing urgent coronary angiography with or without PCI. Routine laboratory parameters were obtained at admission and 48 h. Serum TIMP-2 was measured 2 h after the procedure using a standardized sandwich ELISA. Early CI-AKI was defined by conventional creatinine-based criteria within 48 h, whereas 90-day chronic kidney disease (CKD) was defined as an estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m² or persistent creatinine elevation at 90 days. We evaluated paired changes, between-group differences by 90-day CKD status, correlations, multivariable linear and logistic regression, and receiver operating characteristic (ROC) discrimination.
Results
Early CI-AKI occurred in 6/88 patients (6.8%), whereas 90-day CKD was diagnosed in 15/88 (17%), indicating substantial delayed renal dysfunction beyond the 48-h window. The median 2-h serum TIMP-2 concentration was 1.20 ± 0.38 ng/mL. TIMP-2 showed modest correlations with creatinine and urea and remained independently associated with higher 90-day creatinine in multivariable linear regression (B = + 12.0 µmol/L per 1-ng/mL increase; p = 0.016) after adjustment for baseline creatinine and clinical covariates. In parsimonious logistic models, TIMP-2 demonstrated a borderline association with 90-day CKD (odds ratio ≈ 6.38; p = 0.056), while older age was a significant predictor. Standalone ROC discrimination for 90-day CKD was limited (AUC 0.528; 95% confidence interval 0.39–0.65; p = 0.668).
Conclusions
In STEMI patients undergoing emergent angiography/PCI, 90-day CKD was considerably more frequent than early creatinine-defined CI-AKI, underscoring the need for extended renal follow-up. A single 2-hour serum TIMP-2 measurement reflects early tubular stress and independently associates with 90-day creatinine, but offers only modest standalone discrimination for 90-day CKD. TIMP-2 is therefore more likely to have a role within multivariable or biomarker panel-based risk stratification pathways rather than as an isolated classifier.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medical Care, Anesthesiology and Resuscitation, NJSC Karaganda Medical University, Karaganda, Kazakhstan.
- Department of Obstetrics, Gynecology and Perinatology, NJSC Karaganda Medical University, Karaganda, Kazakhstan. omertaeva@qmu.kz.
Zitieren
APA
Mugazov, M., Saparov, E., Vassilyev, D., Ogizbayeva, A., Vassilyeva, N., & Omertayeva, D. (2026). Early serum TIMP-2 as a biomarker for 90-day chronic kidney disease after percutaneous coronary intervention in ST-elevation myocardial infarction: a prospective cohort study. BMC Cardiovascular Disorders, 26(1). https://doi.org/10.1186/s12872-026-05904-8
Vancouver
Mugazov M, Saparov E, Vassilyev D, Ogizbayeva A, Vassilyeva N, Omertayeva D. Early serum TIMP-2 as a biomarker for 90-day chronic kidney disease after percutaneous coronary intervention in ST-elevation myocardial infarction: a prospective cohort study. BMC Cardiovascular Disorders. 2026;26(1). doi:10.1186/s12872-026-05904-8
BibTeX
@article{Mugazov2026,
author = {Mugazov, Miras and Saparov, Eldar and Vassilyev, Dmitriy and Ogizbayeva, Alina and Vassilyeva, Natalya and Omertayeva, Dinara},
title = {Early serum TIMP-2 as a biomarker for 90-day chronic kidney disease after percutaneous coronary intervention in ST-elevation myocardial infarction: a prospective cohort study},
journal = {BMC Cardiovascular Disorders},
year = {2026},
volume = {26},
number = {1},
doi = {10.1186/s12872-026-05904-8}
}
EUVIMED